Oncology & Hematology Coding Alert

You Be the Coder:

Capture Codes for Rituxan Infusion

Question: How should I code the following case?IV Rituxan, 7:30 AM to 10:30 AM IV Aloxi and Decadron (mixed in one bag), 10:30 AM to 10:50 AM IV Benadryl and Zantac (mixed in one bag), 10:50 AM to 11:10 AMNew Mexico SubscriberAnswer: Your first step is to verify the primary reason for the visit. CPT® guidelines specify that for physician coding you should choose the "initial" code based on the primary reason for the visit. The physician determines what that primary reason is.Assuming the Rituxan (rituximab) therapy is the primary reason for the visit, you should consider the following information for the claim.Rituxan, 180 minutes: Individual payers may choose which agents merit chemotherapy infusion codes rather than non-chemotherapy infusion codes. But for most payers, you should be able to report 96413 (Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug) for the first hour of the [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All